Relypsa, Inc. (RLYP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
31.97+0.01 (+0.03%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close31.96
Bid31.92 x 400
Ask32.00 x 400
Day's Range31.95 - 31.98
52wk Range10.26 - 32.12
1y Target EstN/A
Market Cap1.43B
P/E Ratio (ttm)-5.53
Avg Vol (3m)3,596,412
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire13 days ago

    Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Relypsa, Inc. (RLYP)

    NEW YORK, Aug. 15, 2016-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Relypsa, Inc. in the United States District Court for the Northern District of California ...

  • Highland Capital Management Reveals Investment In Relypsa (RLYP)
    Insider Monkey19 days ago

    Highland Capital Management Reveals Investment In Relypsa (RLYP)

    Relypsa Inc (NASDAQ:RLYP) has proved to be a great short-term investment and  James Dondero is one of those who profited, as his fund, Highland Capital Management has recently initiated a new position. According to a filing with the Securities and Exchange Commission, Dondero and Highland Capital have amassed 5.91 million shares, which amount to approximately […]

  • GlobeNewswire25 days ago

    Galenica commences Tender Offer for Relypsa

    GLATTBRUGG, Switzerland -- Galenica Group today announced that its indirect wholly owned subsidiary, Vifor Pharma USA Inc., is commencing today its previously announced tender offer for any and all outstanding ...